Shenzhen Hepalink Pharmac... (SHEZF)

PNK: SHEZF · Real-Time Price · USD

0.47

0.00 (0.09%)

At close: Apr 30, 2025, 8:00 PM

Shenzhen Hepalink Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Jan 1, 2023	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	1.39B	1.21B	1.23B	1.46B	1.37B	1.38B	1.35B	1.41B	1.3B	1.76B	1.64B	1.85B	1.91B	1.73B	1.52B	1.85B	1.27B	1.79B	883.28M	1.26B	1.4B	1.49B	1.01B	1.11B	1.02B	1.48B	1.12B	1.21B	798.06M	881.94M	738.23M	594.4M	455.64M	617.84M	453.23M	518.55M	671.32M
Cost of Revenue	1.01B	806.63M	868.78M	949.59M	899.55M	924.59M	963.79M	909.9M	846.99M	1.21B	1.12B	1.2B	1.33B	1.16B	1.04B	1.28B	849.9M	1.09B	611.54M	752.04M	787.15M	871.5M	639.75M	731.69M	656.25M	865.01M	677.54M	798.34M	546.25M	654.43M	591.2M	440.04M	344.53M	414.09M	338.14M	361.57M	423.8M
Gross Profit	381.18M	405.16M	362.74M	514.55M	468.72M	457.75M	386.55M	501.98M	454.03M	557.33M	516.22M	645.26M	579.16M	576.45M	474.5M	564.12M	417.98M	696.06M	271.74M	504.84M	615.17M	614.13M	370.4M	374.07M	366.87M	617.94M	446.15M	407.96M	251.82M	227.51M	147.03M	154.36M	111.11M	203.75M	115.09M	156.98M	247.51M
Operating Income	178.98M	-162.17M	120.14M	586.49M	290.3M	-1.04B	14.87M	90.3M	73.65M	-13.29M	211.97M	346.46M	283.49M	-332.55M	140.85M	236.92M	182.26M	481.75M	154.75M	388.5M	304.95M	540.46M	150.02M	43.7M	580.56M	190.53M	244.2M	202.41M	48.53M	-43.26M	44.24M	16.31M	-24.69M	97.81M	39.39M	73.62M	224.79M
Interest Income	9.25M	11.09M	14.69M	28.11M	n/a	n/a	9.51M	35.77M	n/a	n/a	n/a	42.22M	n/a	97.14M	n/a	38.23M	n/a	54.13M	141.12M	11.73M	5.44M	85.6M	27.96M	19.17M	467.2M	120.04M	n/a	n/a	n/a	n/a	15.68M	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	178.24M	-160.97M	119.55M	586.44M	227.4M	-1.11B	13.45M	90.17M	77.56M	-11.24M	212.05M	346.39M	282.65M	-331.4M	138.85M	232.73M	182.09M	480.03M	155.42M	387.37M	305.02M	539.82M	150.32M	43.96M	580.83M	193.27M	247.56M	204.71M	49.8M	-39.4M	46.94M	18.41M	-21.45M	129.27M	44.19M	75.64M	225.83M
Net Income	156.59M	-133.37M	116.43M	508.64M	155.04M	-926.43M	19.82M	56.81M	66.54M	75.17M	141.12M	276.2M	234.94M	-220.72M	123.35M	194.67M	143.48M	315.61M	127.54M	325.77M	255.29M	388.07M	124.88M	39.37M	507.03M	165.31M	206.71M	177.11M	41.99M	78.77M	45.11M	19.53M	-12.08M	93.09M	42.81M	65.11M	195.88M
Selling & General & Admin	191.2M	-135.31M	361.21M	84.48M	176.88M	266.83M	330.53M	97.93M	280.7M	315.76M	389.89M	84.64M	217.16M	-3.72M	320.6M	75.13M	180.82M	-21.37M	176.04M	89.08M	210.51M	11.81M	181.37M	58.22M	161.35M	-45.74M	164.86M	-40M	125.77M	-121.4M	83.6M	-38.85M	114.18M	-133.94M	96.69M	-26.72M	119.31M
Research & Development	39.99M	82.06M	48.94M	47.53M	35.29M	30.21M	56.86M	68.85M	26.51M	85.55M	87.49M	58.22M	20.88M	112.16M	50.67M	40.47M	17.79M	90.6M	34.5M	17.16M	17.75M	36.34M	54.05M	18.75M	39.58M	70.31M	6.45M	49.14M	60.96M	26.02M	26.55M	40.97M	n/a	62.05M	n/a	29.44M	n/a
Other Expenses	-29M	620.58M	-167.54M	-301.36M	33.75M	-69.78M	-21.48M	19.93M	3.91M	169.31M	27.2M	-27.18M	-841.05K	49.27M	2.08M	-8.27M	-170.17K	505.21M	668.55K	34.6M	68.05K	199.09M	307.8K	260.26K	272.95K	2.73M	3.37M	-992.11K	1.26M	3.63M	2.72M	8.72M	3.24M	31.84M	4.9M	2.13M	1.13M
Operating Expenses	202.2M	567.32M	242.61M	-58.01M	178.42M	306.51M	233.56M	313.74M	306.5M	570.62M	308.79M	296.11M	229.86M	396.12M	236.99M	239.16M	196.61M	334.33M	202.16M	196.83M	227.66M	269.32M	236.26M	191.19M	199.72M	272.34M	175.75M	125.13M	123.1M	133.71M	89.8M	109.95M	117.14M	130.45M	99.61M	102.14M	124.91M
Interest Expense	22.45M	30.64M	30.99M	32.36M	35.63M	45.54M	56M	54.67M	50.26M	n/a	56.91M	61.19M	36.92M	49.97M	66.32M	51.14M	8.09M	46.9M	n/a	71.7M	69.03M	69.84M	74.6M	59.56M	n/a	60.74M	48.08M	12.04M	20.29M	85.19M	n/a	53.78M	11.84M	136.93M	n/a	43.39M	n/a
Selling & Marketing Expenses	93.47M	28.38M	126.69M	99.6M	92.31M	114.5M	92.43M	141.61M	168.88M	149.38M	125.56M	123.27M	120.29M	136.43M	99.01M	106.39M	88.67M	116.15M	87.64M	103.88M	101.24M	168.75M	89.67M	93.25M	59.65M	101.2M	54.51M	26.49M	21.86M	31.65M	15.68M	8.42M	7.84M	22.59M	6.05M	6.23M	7.3M
Cost & Expenses	1.22B	1.37B	1.11B	877.66M	1.08B	1.23B	1.2B	1.22B	1.15B	1.78B	1.43B	1.5B	1.56B	1.55B	1.28B	1.52B	1.05B	1.43B	813.7M	948.87M	1.01B	1.14B	876.01M	922.88M	855.97M	1.14B	853.29M	923.46M	669.34M	788.14M	681M	549.99M	461.67M	544.53M	437.75M	463.71M	548.71M
Income Tax Expense	22.07M	-6.83M	3.33M	78.21M	26.61M	-165.46M	-6.07M	33.75M	11.61M	76.22M	72.39M	71.23M	47.41M	-107.72M	18.28M	38.91M	39.41M	164.82M	28.26M	62.76M	50.36M	152.85M	26.92M	5.33M	86.28M	30.03M	45.14M	35.2M	17.87M	-113.27M	3.84M	2.65M	-6.9M	40.89M	2M	12.17M	33.76M
Shares Outstanding (Basic)	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.39B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.24B	1.25B	1.22B	1.43B	1.24B	1.25B
Shares Outstanding (Diluted)	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.52B	1.39B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.24B	1.25B	1.22B	1.43B	1.24B	1.25B
EPS (Basic)	0.11	-0.09	0.08	0.35	0.11	-0.63	0.01	0.04	0.05	0.05	0.10	0.19	0.16	-0.15	0.08	0.13	0.10	0.22	0.09	0.26	0.20	0.31	0.10	0.03	0.41	0.13	0.17	0.14	0.03	0.06	0.04	0.02	-0.01	0.08	0.03	0.05	0.16
EPS (Diluted)	0.11	-0.09	0.08	0.35	0.11	-0.63	0.01	0.04	0.05	0.05	0.10	0.19	0.16	-0.15	0.08	0.13	0.10	0.21	0.09	0.26	0.20	0.31	0.10	0.03	0.41	0.13	0.17	0.14	0.03	0.06	0.04	0.02	-0.01	0.08	0.03	0.05	0.16
EBITDA	200.69M	-130.34M	150.54M	620.86M	226.34M	-1.06B	69.45M	144.84M	139.07M	178.25M	268.97M	407.58M	332.79M	-281.43M	186.92M	283.87M	287.45M	526.93M	198.91M	412.88M	374.05M	609.66M	224.93M	103.51M	634.64M	254M	295.64M	208.48M	145.44M	86.24M	120.73M	69.11M	790.17K	361.81M	15.47M	214.31M	122.61M
EBIT	200.69M	-130.34M	150.54M	620.86M	226.34M	-1.06B	69.45M	144.84M	139.07M	109.78M	200.23M	348.89M	332.79M	-281.43M	186.92M	283.87M	234.55M	526.93M	215.51M	459.06M	374.05M	609.66M	224.93M	103.51M	634.64M	254M	295.64M	208.48M	145.44M	46.26M	120.73M	69.11M	-2.83M	37.11M	15.47M	51.1M	122.61M
Depreciation & Amortization	n/a	n/a	30.41M	34.37M	80.9M	105.84M	105.84M	86.49M	86.49M	68.47M	82.87M	76.23M	76.23M	77.9M	77.9M	75.79M	75.79M	77.89M	63.9M	66.54M	63.9M	63.9M	55.74M	60.61M	55.74M	95.83M	50.47M	10.55M	80.21M	129.49M	16.6M	60.43M	25.48M	275.07M	-13.36M	143.78M	-100.25M